Risk Model for Lymph Node‐Positive Prostate Cancer After Radical Prostatectomy

Documenti analoghi

• Validation study on the 2 mm diameter cutoff in lymph node‐positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real‐world data analysis from a Japanese cohort
  di: Masashi Kato, et al.
  Pubblicazione: (2024)
• Reply to Letter to the Editor on “Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration‐resistant prostate cancer patients”
  di: Tokiyoshi Tanegashima, et al.
  Pubblicazione: (2024)
• Editorial Comment From Dr. Miyake to Effects of Response to First‐Line Chemotherapy Predicts Response to Maintenance Avelumab Therapy in Japanese Patients With Advanced Urothelial Carcinoma
  di: Makito Miyake
  Pubblicazione: (2025)
• Editorial Comment to “Clinical Features and Risk Factors of Enfortumab Vedotin‐Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study ( YUSHIMA Study)”
  di: Makito Miyake
  Pubblicazione: (2026)
• Editorial Comment to Real‐World Outcomes After Radical Cystectomy for Muscle‐Invasive Bladder Cancer in Japan: A Nationwide Descriptive Study From the National Clinical Database
  di: Makito Miyake
  Pubblicazione: (2026)